Market Closed

RIGL
Rigel Pharmaceuticals
$ 44.46
-2.69%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Rigel Pharmaceuticals News

Latest Rigel Pharmaceuticals Stock News & RIGL Headlines

Rigel Pharmaceuticals: Top-Line Momentum Meets Margin Compression In Q3
6 days ago | seekingalpha.com
Rigel Pharmaceuticals Q3 Earnings Call Highlights
9 days ago | marketbeat.com
Rigel Pharmaceuticals, Inc. (RIGL) Q3 2026 Earnings Call Transcript
10 days ago | seekingalpha.com
Rigel Pharmaceuticals (RIGL) Misses Q3 Earnings Estimates
10 days ago | zacks.com
Rigel Reports Third Quarter 2026 Financial Results
10 days ago | prnewswire.com
Rigel Announces Oral Presentation of Phase 1b Data for R289 in Patients with Lower-Risk MDS at the 68th American Society of Hematology Annual Meeting and Exposition
12 days ago | prnewswire.com
Rigel Announces Conference Call and Webcast to Report Third Quarter 2026 Financial Results
18 days ago | prnewswire.com
Rigel Pharmaceuticals: Turning Big Pharma's Castoffs Into A Growth Engine
25 days ago | seekingalpha.com
Rigel Highlights New GAVRETO® (pralsetinib) Data Across RET Fusion-Positive Cancers in Oral and Poster Presentations at ESMO Congress 2026
a month ago | prnewswire.com
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
a month ago | prnewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

RIGL
Rigel Pharmaceuticals
$ 44.46
-2.69%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago